Press Release European Medicines Agency Validates BioMarin’s Marketing Authorization Application for Valoctocogene Roxaparvovec to Treat Severe Hemophilia A
Press Release BioMarin Announces Results for Phase 1 Clinical Study of BMN 195 for Duchenne Muscular Dystrophy
Press Release BioMarin Announces Appointment of Stephen Aselage as Senior Vice President of Global Commercial Operations